FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Megestrol Acetate Suspension
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Par Pharmaceutical (New 12/01/2021)

Company Contact Information:
800-828-9393, option 5 then option 2

Presentation Posting Date Related Information
125mg/1ml, 150ml Bottle (NDC 49884-230-69) 12/01/2021 Par has made a business decision to discontinue this product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English